Clinical Trials List
Protocol NumberKX-ORAX-012
2020-07-24 - 2022-12-31
Phase I
Recruiting1
-
Trial Applicant
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- 吳宜穎 Division of Hematology & Oncology
- 賴學緯 Division of Hematology & Oncology
- 何景良 Division of General Internal Medicine
- 黃子權 Division of Hematology & Oncology
- 張平穎 Division of Hematology & Oncology
- 葉人華 Division of Hematology & Oncology
- 陳宇欽 Division of Hematology & Oncology
- 陳佳宏 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
3~15 participants
-
Global
72 participants
